RAPT Therapeutics Inc.
RAPT
NSD
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
24.60
USD
1.25
(5.35%)
Optionable: Yes Market Cap: 710 M 90-day average vol: 316,050
Previous close: 23.35 Open: 23.82 Bid: 25.25 Ask: 25.25
52 week range
9.86 40.74
Last updated: Wednesday 5th October 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Metrics
Valuation
Price per Sales TTM ($) | 218.52 |
Price per Book TTM ($) | 3.40 |
PE Ratio (TTM) | -9.10 |
Book Value per Share ($) | 6.82 |
5 Year PE Range-14.1 |
Returns
7 Day Return | 2.76% | |
1 Month Return | 6.91% | |
3 Month Return | 28.26% | |
1 Year Return | -21.95% | |
3 Year Return | 89.23% | |
5 Year Return | 89.23% | |
YTD Return | -33.02% |
Risk
Custom Beta One Year | 1.98 |
Custom Beta Three Years | 1.20 |
Beneish M Score | -2.38 |
Altman Z Score | 30.82 |
Analyst Estimates
Financial Health
Technicals
RSI (14 Day) | 50.24 |
14 Day SMA ($) | 24.05 |
14 Day EMA ($) | 24.27 |
Money Flow Index | 40.56 |
Average True Range | 1.89 |
50 Day SMA ($) | 24.59 |
200 Day SMA ($) | 22.05 |
ADX | 29.74 |
MACD | -0.36 |
Growth
Free Cash Flow QoQ Growth | 0.22% |
Free Cash Flow YoY Growth | 0.00% |
Revenue YoY Growth | 0.00% |
EPS QoQ Growth | -10.14% |
Revenue QoQ Growth | 38.22% |
EPS YoY Growth | 0.00% |
Profitability
News
Financials
RAPT Income Statement
Annual
| Invalid date | Aug-10 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | |
|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | 0 | 5 M | 4 M | |
| Cost of sales | -8544 | -1 M | -1 M | -1 M | -2 M | -2 M | |
| Gross operating profit | 0 | 0 | 0 | 0 | 5 M | 4 M | |
| Selling Gen & administrative expense | 123845 | 4 M | 5 M | 9 M | 13 M | 16 M | |
| Research & development expense | 0 | 26 M | 32 M | 35 M | 45 M | 57 M | |
| Operating income | -132766 | -29 M | -37 M | -44 M | -53 M | -69 M | |
| floaterest income | 0 | 0 | 0 | 0 | 0 | 0 | |
| floaterest expense | 0 | 0 | 0 | 0 | 0 | 0 | |
| Other income net | 0 | 216000 | 800000 | 1 M | 1 M | 5000 | |
| Pre-tax Income (EBT) | 0 | -29 M | -36 M | -42 M | -52 M | -69 M | |
| Income taxes | 0 | 0 | 0 | 660000 | 990000 | 0 | |
| Net income from total operations | -132766 | -29 M | -36 M | -43 M | -53 M | -69 M | |
| Minority floaterest | 0 | 0 | 0 | 0 | 0 | 0 | |
| Total net income | -132766 | -29 M | -36 M | -43 M | -53 M | -69 M | |
| Preferred dividends | 0 | N/A | N/A | N/A | N/A | N/A | |
| Net income available for common | -132766 | -29 M | -36 M | -43 M | -53 M | -69 M | |
| Depreciation | 8544 | 1 M | 1 M | 1 M | 2 M | 2 M | |
| Amortization | 8544 | 0 | 0 | 0 | 0 | 0 | |
| Operating income before depreciation (EBITDA) | -124222 | -28 M | -36 M | -42 M | -52 M | -68 M | |
| Total Income available for floaterest expense (EBIT) | 0 | 0 | 0 | 0 | 0 | 0 | |
| Basic EPS total | 0 | -2.01 | -2.09 | -9.89 | -2.19 | -2.53 | |
| Diluted EPS total | 0 | -2.01 | -2.09 | -9.89 | -2.19 | -2.53 |
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONSGet started today